Ovid Therapeutics (OVID) news
Recent news
Lockheed Martin, Avio to produce solid rocket motors
Lockheed Martin and Avio have announced a partnership to produce solid rocket motors, marking a significant development in the aerospace and defense sector. The collaboration aims to leverage the technical expertise and manufacturing capabilities of both companies to meet growing demand for…
AInvest Wire · 1d agoOLVI continuing measures to mitigate cost pressures
AInvest Wire · 1d agoOlvi changes its guidance for 2026
AInvest Wire · 1d agoOvid Therapeutics Inc.: H.C. Wainwright raises target price to $5 from $4
H.C. Wainwright & Co. has raised its price target for Ovid Therapeutics Inc. (OVID) to $5 from $4, reflecting a positive reassessment of the biopharmaceutical company’s outlook. The adjustment suggests increased confidence in Ovid’s strategic direction or recent developments, though specific…
AInvest Wire · Sep 11, 2026Ovid Therapeutics - promotes Charles Carter to chief financial officer
AInvest Wire · Jul 8, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.